Adverse events of Kytril Injection questioned
Friedman, C.; Dolgin, J.G.
Oncology Nursing Forum 26(10): 1587-1589
1999
ISSN/ISBN: 0190-535X PMID: 10573674 Document Number: 6130
Caution must be taken when interpreting any data regarding cardiovascular events in patients receiving cancer chemotherapy because these events could be related to their underlying diseases or their associated treatments.
Document emailed within 1 workday
Related Documents
Bezruchka, S. 2001: Adverse events in British hospitals. Expanded definition of adverse events is needed Bmj 322(7299): 1427Homma, M. 1992: Adverse events and adverse reactions associated with drugs--important actual spontaneous reporting of the drug event Ryumachi 32(5): 429-431
Okada, K. 2011: Adverse events following vaccination Nihon Rinsho. Japanese Journal of Clinical Medicine 69(9): 1639-1643
Yamashita, H.; Tsukayama, H.; Tanno, Y.; Nishijo, K. 1998: Adverse events related to acupuncture JAMA 280(18): 1563-1564
Holzheimer, Ré.G. 2005: Adverse events of sutures: possible interactions of biomaterials? European Journal of Medical Research 10(12): 521-526
Barsky, E. 2014: Serious adverse events related to primary care Soins. Gerontologie 2014(110): 6
Bertelsen, T.; Syversen, K.; Ytteborg, J. 2001: Adverse events in health care services Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 121(1): 105-6; Author Reply 106
Kodama, Y. 2009: Institutional investigations on clinical adverse events Kyobu Geka. Japanese Journal of Thoracic Surgery 62(2): 145-148
Wehrwein, P. 2018: A Wide Angle Lens on Adverse Events Managed Care 27(12): 34-36
Obón Azuara, B.; Gutiérrez Cía, I.; Montoiro Allué, R. 2007: Adverse events by nasogastric tube placement Anales de Medicina Interna 24(9): 461-462
Sandler, A.B. 2006: Nondermatologic adverse events associated with anti-EGFR therapy Oncology 20(5 Suppl. 2): 35-40
Chaovisitsaree, S.; Piyamongkol, W.; Pongsatha, S.; Morakote, N.; Noium, S.; Soonthornlimsiri, N. 2005: One year study of Implanon on the adverse events and discontinuation Journal of the Medical Association of Thailand 88(3): 314-317
James, B.C. 1997: Every defect a treasure: learning from adverse events in hospitals Medical Journal of Australia 166(9): 484-487
Tsukuda, M. 2002: Prevention and treatment for adverse events induced by chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(7): 1284-1291
Koinuma, N.; Takeyoshi, H. 2003: Economic analysis of adverse events in cancer treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 61(6): 1030-1038
O'Hara, D. 1997: Length of hospital stay, adverse events and AN-DRGs Medical Journal of Australia 167(4): 228
Anderson, J.G. 2003: A systems approach to preventing adverse drug events Studies in Health Technology and Informatics 92: 95-102
Sánchez Muñoz, L.A.; Castiella Herrero, J.; Sanjuán Portugal, F.J.; Naya Manchado, J.; Alfaro Alfaro, M.J. 2007: Usefulness of MBDS in detection of adverse drug events Anales de Medicina Interna 24(3): 113-119
Aaraas, I.J.; Jones, B.; Gupta, T.Sen. 2004: Reactions to adverse events among Australian and Norwegian doctors Australian Family Physician 33(12): 1045-1046
Schroeder, S.D. 2016: Quality Focus: First, Do No Harm: Adverse Drug Events South Dakota Medicine: the Journal of the South Dakota State Medical Association 69(12): 565